Christy R Bullard, DO | |
3401 W Gore Blvd, Lawton, OK 73505-6332 | |
(580) 355-8620 | |
Not Available |
Full Name | Christy R Bullard |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Location | 3401 W Gore Blvd, Lawton, Oklahoma |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497178305 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 5530 (Oklahoma) | Secondary |
207Q00000X | Family Medicine | E-10223 (Arkansas) | Secondary |
207P00000X | Emergency Medicine | E-10223 (Arkansas) | Primary |
Entity Name | Comanche County Healthcare Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053352690 PECOS PAC ID: 0749192433 Enrollment ID: O20031106000742 |
News Archive
A protein known to expand blood vessels - key to controlling conditions like high blood pressure - actually has different functions in males and females, new UC Davis Health research shows.
Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
› Verified 4 days ago
Entity Name | Emergency Staffing Solutions Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477590974 PECOS PAC ID: 9830001650 Enrollment ID: O20050207000313 |
News Archive
A protein known to expand blood vessels - key to controlling conditions like high blood pressure - actually has different functions in males and females, new UC Davis Health research shows.
Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
› Verified 4 days ago
Entity Name | Emergency Services Of Oklahoma Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215249891 PECOS PAC ID: 8123209012 Enrollment ID: O20110225000085 |
News Archive
A protein known to expand blood vessels - key to controlling conditions like high blood pressure - actually has different functions in males and females, new UC Davis Health research shows.
Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
› Verified 4 days ago
Entity Name | Ess Of Sallisaw, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215431069 PECOS PAC ID: 6002170578 Enrollment ID: O20180509000869 |
News Archive
A protein known to expand blood vessels - key to controlling conditions like high blood pressure - actually has different functions in males and females, new UC Davis Health research shows.
Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
› Verified 4 days ago
Entity Name | Truepartners Comanche Emergency Specialists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104329697 PECOS PAC ID: 9436414612 Enrollment ID: O20180518000529 |
News Archive
A protein known to expand blood vessels - key to controlling conditions like high blood pressure - actually has different functions in males and females, new UC Davis Health research shows.
Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
› Verified 4 days ago
Entity Name | Elite Hospital Partners Of Oklahoma |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154104404 PECOS PAC ID: 6800241225 Enrollment ID: O20231025002415 |
News Archive
A protein known to expand blood vessels - key to controlling conditions like high blood pressure - actually has different functions in males and females, new UC Davis Health research shows.
Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Christy R Bullard, DO 200 Corporate Blvd, Lafayette, LA 70508-3870 Ph: (800) 893-9698 | Christy R Bullard, DO 3401 W Gore Blvd, Lawton, OK 73505-6332 Ph: (580) 355-8620 |
News Archive
A protein known to expand blood vessels - key to controlling conditions like high blood pressure - actually has different functions in males and females, new UC Davis Health research shows.
Hard to Treat Diseases (HTDS) http://www.htdsmedical.com the company has been asked to comment on recent activity in its stock price. First, we would like our shareholders to be reassured and take comfort in the fact that there is no news that they do not know about. While there are several significant pending transactions they are not ready to be announced yet, however will be in due and appropriate time.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
› Verified 4 days ago
Daniel Dorton, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd # W, Lawton, OK 73505 Phone: 580-699-4322 | |
Dr. Kirk M. Smith, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4909 Se Mills Ave, Lawton, OK 73501 Phone: 580-890-0545 | |
Dr. Justin M Magalassi, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd, Lawton, OK 73505 Phone: 918-519-2011 | |
Dr. Manuel Delarosa, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Nw 67th St, Suite E, Lawton, OK 73505 Phone: 580-536-9400 | |
Ryan Dale Ford, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4510 Sw Wendy Dr, Lawton, OK 73505 Phone: 580-355-8620 | |
Dr. Andrew Burnette, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd, Lawton, OK 73505 Phone: 580-585-5545 | |
David W. Behm, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5602 Sw Lee Blvd, Er Dept, Lawton, OK 73505 Phone: 580-531-4700 Fax: 405-749-4561 |